Hacker News new | past | comments | ask | show | jobs | submit login

Once again I want to profusely thank the HN'er who posted the story about BioNTech and their herpes vaccine in pre-Wuhan Flu October 19. At the time of that story, one could invest in its ipo @ $13.



There are no near-term catalysts for this one anymore.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: